Literature DB >> 33667724

Blockade of HIF-1α and STAT3 by hyaluronate-conjugated TAT-chitosan-SPION nanoparticles loaded with siRNA molecules prevents tumor growth.

Hendrik Setia Budi1, Sepideh Izadi2, Anton Timoshin3, Sima Heydarzadeh Asl4, Behzad Beyzai4, Amir Ghaderpour5, Fatemeh Alian6, Farzaneh Sadat Eshaghi7, Seyedeh Mahboubeh Mousavi4, Behnam Rafiee8, Afshin Nikkhoo4, Armin Ahmadi9, Hadi Hassannia10, Majid Ahmadi11, Mozhdeh Sojoodi12, Farhad Jadidi-Niaragh13.   

Abstract

HIF-1α and STAT3 are two of the critical factors in the growth, proliferation, and metastasis of cancer cells and play a crucial role in inhibiting anti-cancer immune responses. Therefore, we used superparamagnetic iron oxide (SPION) nanoparticles (NPs) coated with thiolated chitosan (ChT) and trimethyl chitosan (TMC) and functionalized with hyaluronate (H) and TAT peptide for delivery of siRNA molecules against STAT3 and HIF-1α to cancer cells both in vivo and in vitro. The results indicated that tumor cell transfection with siRNA-encapsulated NPs robustly inhibited proliferation and migration and induced apoptosis in tumor cells. Furthermore, simultaneous silencing of HIF-1α and STAT3 significantly repressed cancer development in two different tumor types (4T1 breast cancer and CT26 colon cancer) which were associated with upregulation of cytotoxic T lymphocytes and IFN-γ secretion. The findings suggest inhibiting the HIF-1α/STAT3 axis by SPION-TMC-ChT-TAT-H NPs as an effective way to treat cancer.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Chitosan; Hyaluronate; Hypoxia inducible factor; Nanoparticle; SPION; STAT3

Mesh:

Substances:

Year:  2021        PMID: 33667724     DOI: 10.1016/j.nano.2021.102373

Source DB:  PubMed          Journal:  Nanomedicine        ISSN: 1549-9634            Impact factor:   5.307


  4 in total

Review 1.  Current strategies and progress for targeting the "undruggable" transcription factors.

Authors:  Jing-Jing Zhuang; Qian Liu; Da-Lei Wu; Lu Tie
Journal:  Acta Pharmacol Sin       Date:  2022-02-07       Impact factor: 7.169

Review 2.  STAT3 pathway in cancers: Past, present, and future.

Authors:  Han-Qi Wang; Qi-Wen Man; Fang-Yi Huo; Xin Gao; Hao Lin; Su-Ran Li; Jing Wang; Fu-Chuan Su; Lulu Cai; Yi Shi; Bing Liu; Lin-Lin Bu
Journal:  MedComm (2020)       Date:  2022-03-23

Review 3.  Chitosan-Hyaluronic Acid Nanoparticles for Active Targeting in Cancer Therapy.

Authors:  Lisa Efriani Puluhulawa; I Made Joni; Khaled M Elamin; Ahmed Fouad Abdelwahab Mohammed; Muchtaridi Muchtaridi; Nasrul Wathoni
Journal:  Polymers (Basel)       Date:  2022-08-20       Impact factor: 4.967

Review 4.  Emerging nanotechnology-based therapeutics to combat multidrug-resistant cancer.

Authors:  Priya Yadav; Suresh V Ambudkar; N Rajendra Prasad
Journal:  J Nanobiotechnology       Date:  2022-09-24       Impact factor: 9.429

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.